Efficacy and Compliance With Noninvasive Positive Pressure Ventilation in Patients With Chronic Respiratory Failure

Study objectives Previous studies have shown the acute effects of noninvasive positive pressure ventilation (NPPV) in chronic respiratory failure; however, information on the chronic effects of NPPV is limited. We examined the acute and chronic effects of NPPV on gas exchange, functional status, and respiratory mechanics in patients with chronic respiratory failure related to restrictive ventilatory disorders or COPD. Design Descriptive analysis of prospectively collected clinical data. Setting Inpatient noninvasive respiratory care unit and outpatient clinic of university hospital. Patients Forty patients with chronic respiratory failure (20 with severe COPD and 20 with restrictive ventilatory disorders). Interventions and measurements All patients were admitted to a noninvasive respiratory care unit for 20 ± 3 days for inpatient evaluation consisting of medical treatment, rehabilitation, and NPPV evaluation and instruction. NPPV was titrated via a ventilatory support system (BiPAP; Respironics Inc; Monroeville, PA) or a portable volume ventilator (PLV 102; Lifecare, Inc; Boulder, CO) to achieve a ≥ 20% increase in baseline minute ventilation while monitoring gas exchange, expired volume, and clinical evidence of a decrease in the patient's work of breathing. Results The patients' mean age (± SD) was 65 ± 9.7 years, and there was a 3:1 female:male predominance. In the noninvasive respiratory care unit, 36 patients used NPPV for 7.31 ± 0.26 h/night. Four patients (three with COPD, one with restrictive disorder) withdrew from the study during the 3-week inpatient stay because they could not tolerate NPPV. Six patients (5 with COPD, 1 with restrictive disorder) used a portable volume ventilator and 34 patients used BiPAP (15 with COPD, 19 with restrictive disorders). At discharge, compared with at admission, daytime Pa o 2 /fraction of inspired oxygen (F io 2 ) increased (327 ± 10 vs 283 ± 13 mm Hg; p = 0.01), Pa co 2 was reduced (52 ± 2 vs 67 ± 3 mm Hg; p = 0.0001), and functional score increased (4.76 ± 1.16 vs 2.7 ± 1.64 arbitrary units (AUs); p o 2 /F io 2 (317 ± 10 vs 283 ± 13; p = 0.05), Pa co 2 (52 ± 2 vs 67 ± 3 mm Hg; p = 0.0001), and functional score (5.66 ± 0.41 vs 2.7 ± 0.3 AUs; p 1 , and maximum inspired and expired mouth pressures were unchanged before and after long-term NPPV. Ten patients (7 with COPD, 3 with restrictive disorders) discontinued NPPV at 6 months, and 3 progressed to tracheostomy. The remaining 26 patients continued to use NPPV at the 6-month follow-up. They claimed to use NPPV for 7.23 ± 0.24 h/night, but logged metered use was 4.5 ± 0.58 h/night. Problems that required adjustment in either the mask (36%) or ventilator source (36%) included mask leaks (43%), skin irritation (22%), rhinitis (13%), aerophagia (13%), and discomfort from mask headgear (7%). Conclusion NPPV acutely and chronically improves gas exchange and functional status in patients with chronic respiratory failure, but a significant number of patients do not tolerate NPPV on a chronic basis. Comprehensive follow-up is required to correct problems with NPPV and ensure optimal patient compliance.